Synaptogenix Statistics

Total Valuation

Synaptogenix has a market cap or net worth of $3.39 million. The enterprise value is -$14.27 million.

Market Cap	3.39M
Enterprise Value	-14.27M

Important Dates

The next estimated earnings date is Wednesday, May 14, 2025, before market open.

Earnings Date	May 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Synaptogenix has 1.39 million shares outstanding. The number of shares has increased by 164.69% in one year.

Current Share Class	1.39M
Shares Outstanding	1.39M
Shares Change (YoY)	+164.69%
Shares Change (QoQ)	+2.83%
Owned by Insiders (%)	0.66%
Owned by Institutions (%)	4.14%
Float	1.38M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.56
P/TBV Ratio	0.58
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 17.47

Current Ratio	17.47
Quick Ratio	17.41
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -78.91% and return on invested capital (ROIC) is -26.31%.

Return on Equity (ROE)	-78.91%
Return on Assets (ROA)	-17.43%
Return on Invested Capital (ROIC)	-26.31%
Return on Capital Employed (ROCE)	-40.74%
Revenue Per Employee	n/a
Profits Per Employee	-$3.39M
Employee Count	4
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -48.12% in the last 52 weeks. The beta is 1.30, so Synaptogenix's price volatility has been higher than the market average.

Beta (5Y)	1.30
52-Week Price Change	-48.12%
50-Day Moving Average	2.54
200-Day Moving Average	3.11
Relative Strength Index (RSI)	54.27
Average Volume (20 Days)	10,675

Short Selling Information

The latest short interest is 1,433, so 0.10% of the outstanding shares have been sold short.

Short Interest	1,433
Short Previous Month	11,978
Short % of Shares Out	0.10%
Short % of Float	0.10%
Short Ratio (days to cover)	0.11

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-6.81M
Pretax Income	-4.53M
Net Income	-13.56M
EBITDA	-6.81M
EBIT	-6.81M
Earnings Per Share (EPS)	-$10.99

Full Income Statement

Balance Sheet

The company has $17.66 million in cash and n/a in debt, giving a net cash position of $17.66 million or $12.70 per share.

Cash & Cash Equivalents	17.66M
Total Debt	n/a
Net Cash	17.66M
Net Cash Per Share	$12.70
Equity (Book Value)	6.78M
Book Value Per Share	4.32
Working Capital	16.71M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-4.88M
Capital Expenditures	n/a
Free Cash Flow	-4.88M
FCF Per Share	-$3.51

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Synaptogenix does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-164.69%
Shareholder Yield	n/a
Earnings Yield	-399.84%
FCF Yield	-144.03%

Analyst Forecast

The average price target for Synaptogenix is $14.00, which is 495.75% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$14.00
Price Target Difference	495.75%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on April 5, 2024. It was a reverse split with a ratio of 0.04:1.

Last Split Date	Apr 5, 2024
Split Type	Reverse
Split Ratio	0.04:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2